MS-DRG 010Surgical
Pancreas or Islet Cell Transplant
Pre-MDC·Grouped by procedure·FY 2027
MS-DRG 010 is a Surgical Medicare Severity Diagnosis Related Group. For FY 2027 it carries a relative weight of 7.5259 with a geometric mean length of stay of 10.4 days and an arithmetic mean of 15.6 days. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.
Advertisements
FY 2027 payment data
From Table 5 of the FY 2027 IPPS Final Rule (CMS).
- Relative weight:
- 7.5259 (payment multiplier vs. the average case (1.0))
- Geometric mean stay:
- 10.4 days (used for transfer payments)
- Average stay:
- 15.6 days (arithmetic mean)
- Post-acute transfer policy:
- No (not subject to it)
Procedure codes (15)
ICD-10-PCS procedures that can group a stay to DRG 010.
- 0FYG0Z0Transplantation of Pancreas, Allogeneic, Open Approach
- 0FYG0Z1Transplantation of Pancreas, Syngeneic, Open Approach
- 0FYG0Z2Transplantation of Pancreas, Zooplastic, Open Approach
- 3E030U0Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Open Approach
- 3E030U1Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Open Approach
- 3E033U0Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach
- 3E033U1Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach
- 3E0J3U0Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach
- 3E0J3U1Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach
- 3E0J7U0Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
- 3E0J7U1Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
- 3E0J8U0Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
- 3E0J8U1Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
- XW0337CIntroduction of Zimislecel Allogeneic Stem Cell-Derived Islet Cell Therapy into Peripheral Vein, Percutaneous Approach, New Technology Group 12
- XW033DAIntroduction of Donislecel-jujn Allogeneic Pancreatic Islet Cellular Suspension into Peripheral Vein, Percutaneous Approach, New Technology Group 10